Substituted n-propylamine fused heterocyclic mescaline derivatives
Substituted N-propylamine fused heterocyclic mescaline derivatives address the adverse effects of mescaline by modulating receptors and transporters, providing a safer and more effective therapeutic option for neurological disorders.
HK40135073APending Publication Date: 2026-07-17ENVERIC BIOSCIENCES CANADA INC
Patent Information
- Authority / Receiving Office
- HK · HK
- Patent Type
- Applications
- Current Assignee / Owner
- ENVERIC BIOSCIENCES CANADA INC
- Filing Date
- 2026-01-14
- Publication Date
- 2026-07-17
Smart Images
Figure 00000147_0000 
Figure 00000148_0000 
Figure 00000149_0000
Abstract
Disclosed are novel fused myocarine derivative compounds, in particular, substituted N-propylamine fused heterocyclic myocarine derivatives, including substituted N-propylamine fused dioxolane myocarine derivatives, and pharmaceutical and entertaining pharmaceutical formulations containing the same. Methods of making and using these compounds are also disclosed.
Need to check novelty before this filing date? Find Prior Art